CME Group (CME)
(Delayed Data from NSDQ)
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Zacks News
Here's Why You Should Consider Buying CME Group (CME) Stock
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
CME (CME) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
CME (CME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why You Should Retain Intercontinental (ICE) Stock
by Zacks Equity Research
Intercontinental (ICE) to grow on a compelling portfolio, solid pricing and analytics business, a flexible balance sheet and effective capital deployment.
Cboe Global (CBOE) Stock Up 6% YTD: Will the Rally Continue?
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products and solid capital position poise Cboe Global (CBOE) well for growth.
CME Group (CME) Stock Rises 5% YTD: Will the Rally Continue?
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Is Federal Agricultural Mortgage (AGM) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Federal Agricultural Mortgage (AGM) and CME Group (CME) have performed compared to their sector so far this year.
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
Why Is CME (CME) Down 4% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights AbbVie, Intel, Qualcomm, Regeneron and CME Group
by Zacks Equity Research
AbbVie, Intel, Qualcomm, Regeneron and CME Group are included in this Analyst Blog.
Top Research Reports for AbbVie, Intel & Qualcomm
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Intel Corporation (INTC) and Qualcomm Inc. (QCOM).
Are Finance Stocks Lagging CME Group (CME) This Year?
by Zacks Equity Research
Here is how CME Group (CME) and Amerisafe (AMSF) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights CME Group, Intercontinental Exchange, Cboe Global Markets, Nasdaq and Coinbase Global
by Zacks Equity Research
CME Group, Intercontinental Exchange, Cboe Global Markets, Nasdaq and Coinbase Global are part of the Zacks Industry Outlook article.
5 Securities and Exchanges to Gain From Increased Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, ICE, CBOE, NDAQ, and COIN. However, compliance with regulations remains a challenge
Coinbase (COIN) Q1 Earnings Top Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Coinbase (COIN) Q1 results reflect lower trading volumes in both retail and institutional as a result of both lower crypto asset prices and volatility.
Cboe Global (CBOE) Q1 Earnings Beat, Revenues Lag Estimates
by Zacks Equity Research
Cboe Global (CBOE) Q1 results reflect increased adjusted revenues and adjusted earnings, double-digit increases in net transaction and clearing fees, access and capacity fees, which were offset by higher expenses.
Intercontinental (ICE) Q1 Earnings & Revenues Top, Fall Y/Y
by Zacks Equity Research
Intercontinental (ICE) Q1 results reflect a year-over-year revenue decline, attributable to the soft result Mortgage Technology segment. However, lower expenses were a respite.
CME Group (CME) Q1 Earnings and Revenues Beat, Rise Y/Y
by Zacks Equity Research
CME Group (CME) Q1 results reflect higher revenues on increased trading volume.
CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 2.54% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CME Group's (CME) Q1 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services.
Don't Ignore the Relative Strength of These 3 Finance Stocks
by Derek Lewis
While many finance-related stocks have come under pressure following banking concerns, all three of these have displayed relative strength.
Here's How Much a $1000 Investment in CME Group Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Nasdaq (NDAQ) Q1 Earnings Top Estimates, Revenues Increase Y/Y
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter 2023 results reflect organic growth and solid segmental performance.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.